Medicines
How medicine quality affects antimicrobial resistance and the medicines supply chain ...
Avoid product recalls - Know your impurities
Best Practices in State-Level Procurement in India During the COVID-19 Pandemic: Adap...
USP Expands Global COVID-19 Response to Tackle Substandard & Falsified Vaccines...
The challenges posed by COVID-19 transcend international borders and require global solutions. This includes addressing the potential for substandard and falsified (SSF) COVID-19 vaccines, particularly in low- and middle-income countries. At the U.S.
USP Volunteer Profile: Developing the COVID-19 Vaccine Handling Toolkit...
USP’s success in its mission to improve global public health through creation of standards and related programs depends in large part on the work of volunteers.
COVID-19 Vaccine Handling: Maximizing Doses & Public Confidence...
USP’s COVID-19 Vaccine Handling Toolkit is designed to help address the challenges nurses and other healthcare providers face every day in preparing, distributing and administering essential vaccines.
Quality Raw Materials & Collaboration Essential to mAb COVID-19 Treatment Access in L...
Access to quality raw materials and increased stakeholder collaboration are needed to help ensure availability of monoclonal antibody (mAb) treatments for COVID-19 in low- and middle-income countries (LMICs).
Nitrosamine impurities in medicines: what’s the risk?...
In simple terms, risk is the possibility of something bad happening. It’s the uncertainty around the consequences of an activity with respect to something that we value.